Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications

Roscoe O. Brady, William G. Johnson, B. William Uhlendorf

Research output: Contribution to journalEditorial

44 Scopus citations

Abstract

Assay procedures are currently available for the detection of patients and carriers for all nine lipid storage diseases. In six of these conditions reliable determinations may be carried out with commercially available artificial substrates. In the remaining three diseases the use of radioactively labeled lipids is required for enzyme assays. Detection of heterozygotes for Niemann-Pick disease is reported for the first time. A potentially useful artificial substrate is proposed for the detection of patients with Niemann-Pick disease. Automated serum enzyme assays may be useful for large scale screening of heterozygous carriers of lipid storage diseases, and in combination with intrauterine diagnosis could lead to the preventive control of such disorders.

Original languageEnglish (US)
Pages (from-to)423-431
Number of pages9
JournalThe American Journal of Medicine
Volume51
Issue number4
DOIs
StatePublished - Oct 1971
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications'. Together they form a unique fingerprint.

  • Cite this